Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #7456
Ace Report Cover Arthroplasty

Edoxaban has similar efficacy to enoxaparin for thromboprophylaxis after THA

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan

J Arthroplasty. 2014 Dec;29(12):2439-46.

Contributing Authors: T Fuji CJ Wang S Fujita Y Kawai T Kimura S Tachibana

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


264 patients scheduled for total hip arthroplasty were randomized to one of three groups: a group which received 15mg edoxaban daily, a group which received 30mg edoxaban daily, or a group which received 20mg of enoxaparin sodium twice daily. This was done to determine the safety, efficacy, and optimal dosage regimen of edoxaban as compared to enoxaparin in patients undergoing total hip arthroplas...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.